Lilly reports good results in small Alzheimer’s trial
Update: 2025-10-11
Description
Eli Lilly and Company is reporting positive results in a small trial of donanemab (doh-no-nuh-mahb)……an experimental antibody treatment for Alzheimer’s disease.The firm’s announcement comes as the FDA weighs the fate of competitor Biogen’s controversial Alzheimer’s antibody.Biogen asked ....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel